On June 12, 2024, Riot Platforms, Inc. (NASDAQ: RIOT), a Bitcoin mining and digital infrastructure company, publicly criticized Bitfarms Ltd. (NASDAQ/TSX: BITF) for adopting a 'Poison Pill' shareholder rights plan. This plan effectively prevents any shareholder from acquiring more than 15% of Bitfarms' common shares without a formal take-over bid. Riot Platforms, which had previously urged Bitfarms to consult with large shareholders on new board members and called for the resignation of Chairman Nicolas Bonta due to corporate governance concerns, described the Poison Pill as shareholder-unfriendly and a sign of the Bitfarms Board's entrenchment. Riot Platforms emphasized its commitment to addressing corporate governance issues at Bitfarms and ensuring shareholder influence on the company's future. The announcement also mentioned that Riot's proposal for a business combination with Bitfarms is non-binding and subject to change, and that there is no certainty of a definitive offer or transaction completion.

On June 12, 2024, Riot Platforms, Inc. (NASDAQ: RIOT), a Bitcoin mining and digital infrastructure company, publicly criticized Bitfarms Ltd. (NASDAQ/TSX: BITF) for adopting a 'Poison Pill' shareholder rights plan. This plan effectively prevents any shareholder from acquiring more than 15% of Bitfarms' common shares without a formal take-over bid. Riot Platforms, which had previously urged Bitfarms to consult with large shareholders on new board members and called for the resignation of Chairman Nicolas Bonta due to corporate governance concerns, described the Poison Pill as shareholder-unfriendly and a sign of the Bitfarms Board's entrenchment. Riot Platforms emphasized its commitment to addressing corporate governance issues at Bitfarms and ensuring shareholder influence on the company's future. The announcement also mentioned that Riot's proposal for a business combination with Bitfarms is non-binding and subject to change, and that there is no certainty of a definitive offer or transaction completion.